Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy

Current Cardiology Reports

Volumn 3, Issue 2, 2001, Pages 141-146

  Olivotto, Iacopo ^a   Maron, Barry J ^b   Cecchi, Franco ^c  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CHRONIC DISEASE; EMBOLISM; EPIDEMIOLOGY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORTALITY; PATHOPHYSIOLOGY; REVIEW;

ACUTE DISEASE; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CAUSALITY; CHRONIC DISEASE; EMBOLISM; HUMANS;

EID: 0035293972     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-001-0041-x     Document Type: Article

References (50)

1. Maron BJ, Bonow RO, Cannon RO, et al.: Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987, 316:780-789, 844-852.
2. Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
3. Maron BJ: Hypertrophic cardiomyopathy. Lancet 1997, 350:127-133.
4. Maron BJ, Cecchi F, McKenna WJ: Risk factors and current status of risk stratification profiles for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994, 72(Suppl):S13-S18.
5. McKenna WJ, Camm AJ: Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation 1989, 80:1489-1492.
6. Spirito P, Chiarella F, Carratino L, et al.: Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989, 320:749-755.
7. Maron BJ, Olivotto I, Spirito P, et al.: Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral based patient population. Circulation 2000, 102:858-864.
8. Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ: Prognosis in hypertrophic cardiomyopathy: long-term follow-up in a large, unselected outpatient population. Am J Cardiol 1993, 72:939-943.
9. Cannan CR, Reeder GS, Bailey KR, et al.: Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation 1995, 92:2488-2495.
10. Cecchi F, Olivotto I, Montereggi A, et al.: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected population. J Am Coll Cardiol 1995, 26:1529-1536. 11. Maron BJ, Casey SA, Poliac L, et al.: Clinical course of hypertrophic cardiomyopathy in a Regional United States Cohort. JAMA 1999, 281:650-655.
11. Maron BJ, Casey SA, Poliac L, et al.: Clinical course of hypertrophic cardiomyopathy in a Regional United States Cohort. JAMA 1999, 281:650-655.
12. McKenna WJ: Arrhythmia and prognosis in hypertrophic cardiomyopathy. Eur Heart J 1983, 4(Suppl F):225-234.
13. Glancy DL, O'Brien KP, Gold HK, Epstein SE: Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970, 32:652-659.
14. Robinson KC, Frenneaux MP, Stockins B, et al.: Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990, 15:1279-1285.
15. Greenspan AM: Hypertrophic cardiomyopathy and atrial fibrillation: a change of perspective. J Am Coll Cardiol 1990, 15:1286-1287.
16. Stafford WJ, Trohman RG, Bilsker M, et al.: Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986, 7:701-704.
17. Stewart JT, McKenna WJ: Arrhythmias in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1991, 2:516-524.
18. Furlan AJ, Craciun AR, Raju NR, Hart N: Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke 1984, 15:282-284.
19. Suzuki M, Hirayama T, Marumoto K, et al.: Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy -a case report. Angiology 1998, 49:653-657.
20. Higashikawa M, Nakamuri Y, Yoshida M, Kinoshita M: Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. Jpn Circ J 1997, 61:673-681.
21. Shigematsu Y, Hamada M, Mukai M, et al.: Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J 1995, 59:329-336.
22. Kogure S, Yamamoto Y, Yomono S, et al.: High risk of systemic embolism in hypertrophic cardiomyopathy. Jpn Heart J 1986, 27:475-480.
23. Brembilla-Perrot B, Terrier de La Chaise A, Beurrier D: Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy. Arch Mal Coeur Vaiss 1993, 86:1573-1578.
24. Olivotto I, Cecchi F, Santoro G, et al.: Atrial fibrillation is an important determinant of outcome in patients with hypertrophic cardiomyopathy [abstract]: 72nd Session of the American Heart Association. Circulation 1999, 100:I76.
25. Maron BJ, Spirito P, Green KJ, et al.: Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987, 10:733-742.
26. Bonow RO, Frederick TM, Bacharach SL, et al.: Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 1983, 51:1386-1391.
27. Losi MA, Betocchi S, Grimaldi M: Heterogeneity of left ventricular filling dynamics in hypertrophic cardiomyopathy. Am J Cardiol 1994, 73:987-990.
28. Spirito P, Lakatos E, Maron BJ: Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol 1992, 69:1217-1222.
29. Spirito P, Maron BJ, Bonow RO, Epstein SE: Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiornyopathy. Am J Cardiol 1987, 60:123-129.
30. Panza JA, Petrone RK, Fananapazir L, Maron BJ: Utility of continuous wave Doppler in noninvasive assessment of the left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992, 19:91-99.
31. Wigle ED, Adelman AG, Auger P, Marquis Y: Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 1969, 24:698-706.
32. Petrone RK, Klues HG, Panza JA, et al.: Significance of the occurrence of mitral valve prolapse in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992, 20:55-61.
33. Gruver EJ, Fatkin D, Dodds GA, et al.: Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 1999, 83:13H-18H.
34. Cecchi F, Montereggi A, Olivotto I, et al.: Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by Signal-averaged P-wave. Heart 1997, 78:44-49.
35. Cannon RO, Rosing DR, Maron BJ, et al.: Myocardial ischemia in hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985, 71:234-243.
36. O'Gara PT, Bonow RO, Maron BJ, et al.: Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987, 76:1214-1223.
37. Di Pasquale G, Andreoli A, Lusa AM, et al.: Cerebral embolic risk in hypertrophic cardiomyopathy. In Advances in Cardiomyopathies. Edited by Baroldi G, Camerini F, Goodwin J. Milano: Springer Verlag; 1990:91-96.
38. Frenneaux MP, Counihan PJ, Caforio ALP, et al.: Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1991, 82:1995-2002.
39. Levy S, Breithardt G, Campbell RW, et al.: Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998, 19:1294-1320.
40. Cecchi F, Maron BJ, Epstein SE: Long-term outcome of patients with hypertrophic cardiomyopahy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989, 13:1283-1288.
41. Benjamin EJ, Wolf PA, D'Agostino RB, et al.: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998, 98:946-952.
42. Maron BJ, Spirito P: Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993, 72:970-972.
43. Maron BJ, Spirito P, Bellone P, et al.: Prevalence and clinical profile of stroke and other peripheral embolizations in patients with hypertrophic cardiomyopathy: a United States and Italy cooperative study [abstract]. J Am Coll Cardiol 1998, 31(Suppl A):26A.
44. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991, 84:40-48
45. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS: Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988, 61:714-717.
46. Cecchi F, Olivotto I, Montereggi A, et al.: Prognostic value of nonsustained ventricular tachycardia and efficacy of amiodarone treatment in an unselected patient population with hypertrophic cardiomyopathy. Heart 1998, 79:331-336.
47. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985, 53:412-416.
48. Tendera M, Wycisk A, Schneeweiss A, et al.: Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. Cardiology 1993, 82:335-342.
49. Savage DD, Seides SF, Maron BJ, et al.: Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979, 59:866-875.
50. McKenna WJ, England D, Doi YL, et al.: Arrhythmia in hypertrophic cardiomyopathy: I -Influence on prognosis. Br Heart J 1981, 46:168-172.